Cryo-EM Maps NSUN2 RNA Methylation at 2.57 Å, Defining a Dual-Stem CNNRR Target
Updated
Updated · Nature.com · May 27
Cryo-EM Maps NSUN2 RNA Methylation at 2.57 Å, Defining a Dual-Stem CNNRR Target
1 articles · Updated · Nature.com · May 27
Researchers captured human NSUN2 in nine cryo-EM structures, including a 2.57-angstrom reaction intermediate, showing how the enzyme binds RNA through multiple catalytic stages to install m5C marks.
The structures show NSUN2 recognizes RNA shape more than sequence: two surrounding duplex stems are essential, while SAM cofactor binding locks the target cytidine into the active site for methylation.
Biochemical tests found NSUN2 favors tRNA positions 48 and 49 over 50 and can methylate different RNAs using the same geometry, with purines in a preferred CNNRR motif boosting activity.
Using those rules, the team built a minimal 39-nucleotide substrate from a 76-nucleotide tRNA and extended the dual-stem model to non-tRNA targets including lncRNA RP11 and pre-tRNA LeuCAA intron fragments.
The work offers a framework for interpreting disease-linked NSUN2 mutations—implicated in cancers and neurological disorders—and for designing drugs that modulate NSUN2-dependent RNA methylation.
With its cancer-driving blueprint revealed, can we now design drugs to precisely disable the NSUN2 enzyme?
If RNA's 3D shape is a hidden code, what other biological mysteries could this new perspective unlock?
From Atomic Structures to Precision Medicine: NSUN2 RNA Methylation as a Target for Cancer and Neurological Disorders
Overview
This report highlights a major scientific breakthrough where researchers achieved atomic-resolution images of the NSUN2 methyltransferase as it modifies RNA. Using high-resolution cryo-EM, they captured NSUN2 in action with its RNA substrate, revealing the enzyme’s precise molecular structure and how it interacts with RNA during methylation. By analyzing multiple structural snapshots at different stages of the catalytic cycle, the study uncovers the dynamic process of RNA modification. These insights provide a deeper understanding of RNA epigenetics and lay the groundwork for future advances in disease diagnostics and targeted therapies.